Institutional members access full text with Ovid®

Share this article on:

The International Society of Hypertension and World Hypertension League call on governments, nongovernmental organizations and the food industry to work to reduce dietary sodium

The Executive Board of the World Hypertension League:; Campbell, Norman R.C.a; Lackland, Daniel T.b; Chockalingam, Arunc; Lisheng, Liud; and the Executive Committee of the International Society of Hypertension:; Harrap, Stephen B.f; Touyz, Rhian M.k; Burrell, Louise M.e; Ramírez, Agustín J.h; Schmieder, Roland E.i; Schutte, Aletta E.j; Prabhakaran, Dorairajg; Schiffrin, Ernesto L.l

doi: 10.1097/HJH.0000000000000079
Ish News

The International Society of Hypertension and the World Hypertension League have developed a policy statement calling for reducing dietary salt. The policy supports the WHO and the United Nations recommendations, which are based on a comprehensive and up-to-date review of relevant research. The policy statement calls for broad societal action to reduce dietary salt, thus reducing blood pressure and preventing hypertension and its related burden of cardiovascular disease. The hypertension organizations and experts need to become more engaged in the efforts to prevent hypertension and to advocate strongly to have dietary salt reduction policies implemented. The statement is being circulated to national hypertension organizations and to international nongovernmental health organizations for consideration of endorsement. Member organizations of the International Society of Hypertension and the World Hypertension League are urged to support this effort.

aLibin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada

bDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA

cInstitute of Global Health Equity and Innovation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

dFu Wai Hospital, Chinese Academy of Medical Sciences, Beijing Hypertension League Institute, Beijing, China

eDepartment of Medicine, The University of Melbourne, Austin Health

fDepartment of Physiology The University of Melbourne, Heidelberg, Victoria, Australia

gCentre for Chronic Disease Control (CCDC), New Delhi, India

hArterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina

iUniversity Hospital of the University Erlangen-Nuremberg, Nephrology and Hypertension, Ulmenweg, Erlangen, Germany

jHypertension in Africa Research Team, North-West University, Potchefstroom, South Africa

kInstitute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK

lSir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, Department of Medicine, McGill University, Montreal, Quebec, Canada

Correspondence to Ernesto L. Schiffrin, CM, MD, PhD, FRSC, FRCPC, FACP, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, Department of Medicine, McGill University, #B-127, SMBD-Jewish General Hospital, 3755 Côte-Ste-Catherine Rd., Montreal, QC H3T 1E2, Canada.Tel: +1 514 340 7538; fax: +1 514 340 7539; e-mail: ernesto.schiffrin@mcgill.ca

Received 13 November, 2013

Accepted 20 November, 2013

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins